TABLE 2.
Cardiovascular drugs withdrawn due to their adverse effects on the cardiovascular system
| Medicinal product | Class | Reason for withdrawal |
|---|---|---|
| Prenylamine | Antianginal | Cardiovascular: multifactorial ventricular tachycardia |
| Adenosine phosphate | Antiarrhythmic | Cardiovascular |
| Bepridil | Antiarrhythmic | Cardiovascular |
| Dofetilide | Antiarrhythmic | Cardiovascular |
| Encainide | Antiarrhythmic | Cardiovascular |
| Gallopamil | Antiarrhythmic | Not specified, cardiovascular |
| Hydrochlorothiazide+sotalol | Antihypertensive | Cardiovascular, drug interactions |
| Nifedipine (10mg) | Antihypertensive | Cardiovascular |
| Isoprenaline | Cardiac stimulant | Cardiovascular |
| Buflomedil | Vasodilator | Neurotoxicity, cardiotoxicity |
| Indoramin | Vasodilator | Cardiovascular |
| Naftidrofuryl oxalate (IV) | Vasodilator | Cardiovascular, immunologic, liver, urinary tract |
| Levarterenol | Vasopressor | Nervous, cardiovascular |